Becton, Dickinson and Co. (BDX)

Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)

Market region: US

Address: One Becton Dr, Franklin Lakes, NJ, 07417-1880

Market capitalization

53.90 billion USD (53,899,899,984 USD)

Listing date

09/25/1963

Weighted shares outstanding

272,386,800

Share class shares outstanding

275,540,427

https://www.bd.com